TRDA ▲ +1.4% - Entrada Therapeutics, Inc. $TRDA - Entrada Therapeutics Announces Recipients of Fourth Annual DREAMS Grant Program Entrada Therapeutics announced the recipients of its fourth annual DREAMS Grant Program, a move that likely reinforced investor confidence in the company's commitment to supporting external research and development initiatives. The stock rose 1.4% on the news, suggesting the market viewed the grant program announcement positively as a demonstration of the company's scientific leadership and community engagement. 10-SEP-2026 07:00 AM ET